GLP-1 Archives

Healthcare Industry News Weekly Wrap-Up: May 2, 2024

// Biotech and Pharma Therapeutics FTC targets ‘junk patents’ on Ozempic, other top drugs May 1, 2024 / Ozempic / FDA / Drug Pricing / FDA The FTC is targeting over 300 patents associated with top-selling drugs like Ozempic, aiming...

May 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

// Biotech and Pharma Therapeutics Bristol Myers taps startup to boost cell therapy production April 22, 2024 / Cell Therapy / CAR-T Therapies / Bristol Myers Squibb / Partnership Bristol Myers Squibb has partnered with Cellares, a California-based startup, to...

April 25, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

// Biotech and Pharma Therapeutics Lilly obesity drug shows benefit in sleep disorder study, pointing to new use April 17, 2024 / Eli Lilly / Obesity / Sleep Disorder / GLP-1 / Clinical Trials Fresh clinical trial results for Eli...

April 18, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 21, 2024

// Biotech and Pharma Therapeutics Following Boehringer’s lead, AstraZeneca ⁠caps monthly out-of-pocket inhaler costs at $35 in the US March 18, 2024 / AstraZeneca / Symbicort / Inhaled Medicines / Asthma AstraZeneca on Monday revealed it’s expanding a savings program...

March 21, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 15, 2024

// Biotech and Pharma Therapeutics Can biotechnology lead the way toward a sustainable pharmaceutical industry? March 14, 2024 / Biotechnology / Sustainability / PharmaceuticalsExamine the environmental sustainability of the pharmaceutical industry, highlighting that only a small fraction of drugs have...

March 15, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Tag: GLP-1

Healthcare Industry News Weekly Wrap-Up: May 2, 2024

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

Healthcare Industry News Weekly Wrap-Up: March 21, 2024

Healthcare Industry News Weekly Wrap-Up: March 15, 2024

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: GLP-1

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺